4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-041528
Director sold 11,000 shares at an average $257.48 ($2,832,335)
- Director acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Richard S Director | 2024-04-01 | Option exercise 10b5-1 | +5,000 | $7.36 | $36,800 | 15,298 | D |
| Levy Richard S Director | 2024-04-01 | Option exercise 10b5-1 | +6,000 | $111.06 | $666,360 | 21,298 | D |
| Levy Richard S Director | 2024-04-01 | Sale 10b5-1 | −4,387 | $255.90 | $1,122,629 | 16,911 | D |
| Levy Richard S Director | 2024-04-01 | Sale 10b5-1 | −3,900 | $256.88 | $1,001,836 | 13,011 | D |
| Levy Richard S Director | 2024-04-01 | Sale 10b5-1 | −1,600 | $257.93 | $412,696 | 11,411 | D |
| Levy Richard S Director | 2024-04-01 | Sale 10b5-1 | −100 | $259.07 | $25,907 | 11,311 | D |
| Levy Richard S Director | 2024-04-01 | Sale 10b5-1 | −713 | $265.28 | $189,145 | 10,598 | D |
| Levy Richard S Director | 2024-04-01 | Sale 10b5-1 | −300 | $267.07 | $80,122 | 10,298 | D |
| Derivatives | |||||||
| Levy Richard S Director | 2024-04-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 15,000 | D | ||
| Levy Richard S Director | 2024-04-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 0 | D | ||
| Open-market sales · 11,000 sh · avg $257.48 · $2,832,335 | |||||||
Loading xslF345X05/ownership.xml…